Enhanced immune responses in mice to combined immunization with Mycobacterium tuberculosis Ag85A and DDA/MPL

Dan Zhao; Weijun Tan; Zhengzhong Xu; Xiang Chen; Shuyang Ye; Kai Lian; Zhiming Pan; Yuelan Yin*; Xinan Jiao*

doi:10.5897/AJMR2014.6800

African Journal of
Microbiology Research

Abbreviation: Afr. J. Microbiol. Res.
Language: English
ISSN: 1996-0808
DOI: 10.5897/AJMR
Start Year: 2007
Published Articles: 5233

Full Length Research Paper

Enhanced immune responses in mice to combined immunization with Mycobacterium tuberculosis Ag85A and DDA/MPL

Dan Zhao

Dan Zhao
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Weijun Tan

Weijun Tan
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Zhengzhong Xu

Zhengzhong Xu
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Xiang Chen

Xiang Chen
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Shuyang Ye

Shuyang Ye
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Kai Lian

Kai Lian
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Zhiming Pan

Zhiming Pan
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Yuelan Yin*

Yuelan Yin*
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Xinan Jiao*

Xinan Jiao*
Jiangsu Key Laboratory of Zoonosis, Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Disease and Zoonoses, Jiangsu Province, Yangzhou University, Yangzhou 225009, Jiangsu, China
Search for this author on:
Google Scholar

Article Number - 546EE0C45872
Vol.8(27), pp. 2656-2664 , July 2014
https://doi.org/10.5897/AJMR2014.6800

Received: 28 March 2014
Accepted: 13 June 2014
Published: 02 July 2014

References

Armitige LY, Jagannath C, Wanger AR, Norris SJ (2000). Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect immun. 68(2):767-778. Crossref

Betts G, Poyntz H, Stylianou E, Reye-Sandoval A, Cottingham M, Hill A, McShane H (2012). Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection. PLoS One 7(12): e50447. Crossref

Borremans M, de Wit L, Volckaert G, Ooms J, de Brujn J, Huygen K, van Vorren J, Stelandre M, Verhofstadt R, Content J (1989). Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect immun. 57(10):3123-3130. Pubmed

Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P (2000). ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect immun. 68(2):791-795. Crossref

Dai J, Pei D, Wang B, Kuang Y, Ren L, Cao K, Zuo B, Shao J, Li S, Jiang Z, Li H, Li M (2013). A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. Virol. J. 10:40. Crossref

Dai J, Pei D, Wang BN. Kuang Y, Ren L, Cao K, Wang H, Zuo B, Shao J, Li S, Li H, Li M (2012). Molecular adjuvant Ag85A enhances protection against influenza A virus in mice following DNA vaccination. Viruses 4(12): 3606-3624. Crossref

Fan X, Gao Q, Fu R (2009). Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model. Microbiol. Res. 164(4): 374-382. Crossref

Hu S, Chen H, Ma J, Chen Q, Denq H, Gong F, Huang H, Shi C (2013). CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection. J. Appl. Microbiol. 115(5):1203-1211. Crossref

Kaufmann SH (2005). Recent findings in immunology give tuberculosis vaccines a new boost. Trends Immunol. 26(12): 660-667. Crossref

Korsholm KS, Agger EM, Foged C, Christensen D, Dietrich J, Andersen CS, Geisler C, Andersen P (2007). The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology 121(2):216-226. Crossref

Korsholm KS, Petersen RV, Agger EM, Andersen P (2010). T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection. Immunology 129(1):75-86. Crossref

Launois P, Deleys R, Niang MN, Drowart A, Andrien M, Dierckx P, Cartel JL, Sarthou JL, Van Vooren JP, Huygen K (1994). T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun. 62(9):3679-3687. Pubmed

Lozes E, Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Vandenbussche P, Van Vooren JP, Drowart A, Ulmer JB, Liu MA (1997). Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15(8):830-833. Crossref

Lu J, Wang C, Zhou Z, Zhang Y, Cao T, Shi C, Chen Z, Chen L, Cai C, Fan X (2011). Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein. Clin. Dev. Immunol. 2011:617892. Crossref

Magalhaes I, Sizemore DR, Ahmed RK, Muellar S, Wehlin L, Scanga C, Weichold F,Schirru G, Pau MG, Goudsmit J, Kuhlmann-Berenzon S, Spangberg M, Andersson J, Gaines H, Thorstensson R, Skeiky YA, Sadoff J, Maeurer M (2008). rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS One 3(11):e3790. Crossref

Pal PG, Horwitz MA (1992). Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60(11): 4781-4792. Pubmed

Rahman S, Magalhaes I, Rahman J, Ahmed RK, Sizemore DR, Scanga CA, Weichold F, Verreck F, Kondova I, Sadoff J, Thorstensson R, Spangberg M, Svensson M, Andersson J, Maeurer M, Brighenti S (2012). Prime-boost vaccination with rBCG/rAd35 enhances CD8+ cytolytic T-cell responses in lesions from Mycobacterium Tuberculosis -infected primates. Mol. Med. 18:647-658. Crossref

Roberts AD, Sonnenberg MG, Ordwy DJ, Furney SK, Bernnan PJ, Belisle JT, Orme IM (1995). Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85(3): 502-508. Pubmed

Rodrigues LC, Pereira SM, Cunha SS, Genser B, Ichihara MY, de Brito SC, Hijjar MA, Dourado I, Cruz AA, Sant'Anna C, Bierrenbach AL, Barreto ML (2005). Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 366(9493):1290-1295. Crossref

Romano M, Roupie V, Wang XM, Denis O, Jurion F, Adnet PY, Laali R, Huygen K (2006). Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3. Immunology 118(3):321-332. Crossref

Spencer AJ, Hill F, Honeycutt JD, Cottingham MG, Bregu M, Rollier CS, Furze J, Draper SJ, Sogaard KC, Gilbert SC, Wyllie DH, Hill AV (2012). Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primates. PLoS One 7(3):e 33555.

Sugawara I, Udagawa T, Taniyama T (2007). Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A. Tuberculosis (Edinb). 87(2):94-101. Crossref

Tanghe A, Denis O, Lambrecht B, Motte V, van den Berg T, Huygen K (2000). Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect. Immun. 68(7):3854-3860. Crossref

Wang C, Fu R, Chen Z, Tan K, Chen L, Teng X, Lu J, Shi C, Fan X (2012). Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B. Clin. Dev. Immunol. 2012: 583838. Crossref

Xie Y, Bao L, Hu C, Zhang W, Chen W (2002). Molecular cloning and expression of the immunodominant protein Ag85A from Mycobacterium tuberculosis H37Rv strain. Hua Xi Yi Ke Da Xue Xue Bao 32(2):172-174.